Funding and People - Articles

So, as the ‘white wine’-induced hangover wears off, I realise that I have a new addiction: China.

China is a heady drug for anyone involved in biotech, cleantech or IT, representing a massive potential market, a source of significant funding – both in terms of grant and investment – and offering the potential for rapid product development. It is also a frightening, challenging, bureaucratic, unknown business environment with alien culture and, at first sight, inpenetrable language.

This series of blogs will chart my progress or ...